SCHEMBL17875757

SCHEMBL17875757

c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc4c(c3)-c3ccc(-c5cc(-c6ccccc6)nc(-c6ccccc6)c5)cc3CSC4)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.38
MEN1 O00255 6/20 0.38
KMT2A Q03164 6/20 0.38
TDP2 O95551 1/20 0.38
MYC P01106 1/20 0.37
PARP10 Q53GL7 1/20 0.37
PARP11 Q9NR21 1/20 0.37
TYRO3 Q06418 1/20 0.35
NTRK2 Q16620 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
MAPT P10636 4/20 0.35
MCL1 Q07820 2/20 0.35
KDM4E B2RXH2 2/20 0.35
CTRC Q99895 1/20 0.34
PDK2 Q15119 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
ADORA1 P30542 2/20 0.33
NPC1 O15118 2/20 0.33
LMNA P02545 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875751 1.00 CYP19A1 (0.38) CYP19A1MEN1KMT2ATDP2MYC
SCHEMBL17875787 0.97 MAPT (0.37) CYP19A1MEN1KMT2ATDP2MYC
SCHEMBL17875810 0.94 CYP19A1 (0.41) CYP19A1MEN1KMT2ATDP2MYC
SCHEMBL17875809 0.92 MAPT (0.40) CYP19A1MEN1KMT2AMYCTYRO3
SCHEMBL17875749 0.90 TDP2 (0.44) MEN1KMT2ATDP2PARP10PARP11
SCHEMBL17875754 0.89 CYP19A1 (0.50) CYP19A1TDP2KDM4EPDK2RAB9A
SCHEMBL17875770 0.89 CYP19A1 (0.50) CYP19A1TDP2KDM4EPDK2RAB9A
SCHEMBL17875803 0.84 HCRTR1 (0.33) MEN1KMT2AMYCMAPTKDM4E
SCHEMBL17875738 0.84 HCRTR1 (0.33) MEN1KMT2AMYCMAPTKDM4E
SCHEMBL17875763 0.84 KMT2A (0.35) MEN1KMT2AMYCMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP19A1 167/4885MEN1 448/4885KMT2A 1757/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP19A1 167/4885MEN1 448/4885KMT2A 1757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.